A pilot study for the analgesic effect of Open-label Placebo (OLP): Comparison of OLP Acupuncture and OLP Pills

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CRIS

Registry ID

KCT0004928

Enrollment

Registered

2020-04-16

Start date

2020-04-20

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(placebo pill

placebo needle) : Participants will receive placebo pill , placebo needle, no treatment in a randomized order. Placebo pill treatment Participants will lie comfortably on a chair and take the placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy men and women(Age 19~40)

Exclusion criteria

Exclusion criteria: (1) Patients with cardiovascular disease, infectious disease, diabetes, any type of pain disease, or patients taking anticoagulant agents. (2) Patients with cognitive impairment. (3) Participants who are Left-handed. (4) Participants with skin disease on fingers. (5) Participants with sensory abnormalities.

Design outcomes

Primary

Measure	Time frame
Pain threshold;Subjective pain intensity in VAS	—

Secondary

Measure	Time frame
Subjective unpleasantness intensity in VAS	—

Countries

Korea, Republic of

Contacts

Public ContactYounbyoung Chae

Kyung Hee University

Outcome results